PL356908A1 - Compositions and methods for the therapy and diagnosis of prostate cancer - Google Patents
Compositions and methods for the therapy and diagnosis of prostate cancerInfo
- Publication number
- PL356908A1 PL356908A1 PL01356908A PL35690801A PL356908A1 PL 356908 A1 PL356908 A1 PL 356908A1 PL 01356908 A PL01356908 A PL 01356908A PL 35690801 A PL35690801 A PL 35690801A PL 356908 A1 PL356908 A1 PL 356908A1
- Authority
- PL
- Poland
- Prior art keywords
- diagnosis
- therapy
- compositions
- methods
- prostate cancer
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464493—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; Prostatic acid phosphatase [PAP]; Prostate-specific G-protein-coupled receptor [PSGR]
- A61K39/464494—Prostate specific antigen [PSA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48367200A | 2000-01-14 | 2000-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL356908A1 true PL356908A1 (en) | 2004-07-12 |
Family
ID=23921037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL01356908A PL356908A1 (en) | 2000-01-14 | 2001-01-16 | Compositions and methods for the therapy and diagnosis of prostate cancer |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1261708A2 (en) |
JP (1) | JP2003528591A (en) |
KR (1) | KR20030016217A (en) |
CN (1) | CN1436234A (en) |
AU (1) | AU3447401A (en) |
BR (1) | BR0107643A (en) |
CA (1) | CA2397741A1 (en) |
CZ (1) | CZ20022756A3 (en) |
HU (1) | HUP0203968A3 (en) |
IL (1) | IL150732A0 (en) |
MX (1) | MXPA02006934A (en) |
NO (1) | NO20023402L (en) |
PL (1) | PL356908A1 (en) |
RU (1) | RU2002121771A (en) |
WO (1) | WO2001051633A2 (en) |
ZA (1) | ZA200206400B (en) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7241876B2 (en) | 1996-01-11 | 2007-07-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US20030125536A1 (en) * | 1996-01-11 | 2003-07-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6828431B1 (en) | 1999-04-09 | 2004-12-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US20030185830A1 (en) | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6630305B1 (en) | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7033827B2 (en) | 1997-02-25 | 2006-04-25 | Corixa Corporation | Prostate-specific polynucleotide compositions |
US6800746B2 (en) | 1997-02-25 | 2004-10-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6620922B1 (en) | 1997-02-25 | 2003-09-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7202342B1 (en) | 1999-11-12 | 2007-04-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6613872B1 (en) | 1997-02-25 | 2003-09-02 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US6465611B1 (en) | 1997-02-25 | 2002-10-15 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US6329505B1 (en) | 1997-02-25 | 2001-12-11 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
US6759515B1 (en) | 1997-02-25 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6894146B1 (en) | 1997-02-25 | 2005-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6943236B2 (en) | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6818751B1 (en) | 1997-08-01 | 2004-11-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
ATE426018T1 (en) | 1997-04-10 | 2009-04-15 | Stichting Katholieke Univ | PCA3, PCA3 GENES AND METHODS FOR USE THEREOF |
US6861215B1 (en) | 1998-05-21 | 2005-03-01 | Diadexus, Inc. | Method of diagnosing, monitoring, and staging prostate cancer |
US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
AU757698C (en) | 1998-06-01 | 2004-04-08 | Agensys, Inc. | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
US7022497B1 (en) | 1999-03-11 | 2006-04-04 | Mt. Sinai Hospital | Human kallikrein-like genes |
US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
ES2260059T3 (en) | 1999-09-29 | 2006-11-01 | Diagnocure Inc. | RNA MESSENGER OF PCA3 IN BENIGN AND MALIGNED PROSTATE FABRICS. |
US6790631B1 (en) | 1999-10-05 | 2004-09-14 | Agensys, Inc. | G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
US7361338B2 (en) | 1999-10-05 | 2008-04-22 | Agensys, Inc. | Methods to inhibit growth of prostate cancer cells |
DE60033583T2 (en) * | 1999-10-07 | 2007-09-13 | Corixa Corp. CSC, Wilmington | A MYCOBACTERIUM TUBERCULOSIS ENCODING SEQUENCE FOR THE EXPRESSION OF HETEROLOGICAL PROTEINS |
US20020048777A1 (en) | 1999-12-06 | 2002-04-25 | Shujath Ali | Method of diagnosing monitoring, staging, imaging and treating prostate cancer |
CA2403909A1 (en) * | 2000-03-27 | 2001-10-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
ATE442866T1 (en) | 2000-06-20 | 2009-10-15 | Corixa Corp | FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS |
AU2001281322A1 (en) * | 2000-07-13 | 2002-01-30 | Biogen, Inc. | Methods of identifying renal protective factors |
CA2417671A1 (en) * | 2000-07-28 | 2002-02-07 | Ulrich Wissenbach | Trp8, trp9 and trp10, novel markers for cancer |
US7048931B1 (en) | 2000-11-09 | 2006-05-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
WO2002083921A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
WO2002089747A2 (en) * | 2001-05-09 | 2002-11-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6897024B2 (en) | 2001-05-31 | 2005-05-24 | Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen | Nucleic acid molecules comprising the promoter for PCA3, and uses thereof |
US20050272120A1 (en) | 2001-06-20 | 2005-12-08 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
KR100788092B1 (en) | 2001-06-20 | 2007-12-21 | 제넨테크, 인크. | Compositions and Methods for the Diagnosis and Treatment of Tumor |
ES2537074T3 (en) * | 2001-09-06 | 2015-06-02 | Agensys, Inc. | Nucleic acid and corresponding protein called STEAP-1 useful in the treatment and detection of cancer |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
WO2003064602A2 (en) | 2002-01-25 | 2003-08-07 | The Regents Of The University Of California | Methods of modulating cold sensory perception |
DE10215321A1 (en) * | 2002-04-02 | 2003-10-23 | Metagen Pharmaceuticals Gmbh | New nucleic acid encoding Trpp8 splice variants, useful for diagnosis of prostatic cancer, and to screen for diagnostic or therapeutic agents, also related proteins |
PT1511768E (en) * | 2002-06-11 | 2007-07-16 | Glaxo Group Ltd | Immunogenic compositions |
DE10234901A1 (en) * | 2002-07-26 | 2004-02-12 | Metagen Pharmaceuticals Gmbh | New nucleic acids encoding Mrp4, useful in the diagnosis of prostatic, bladder and ovarian tumors, also in screening for specific binding agents, and potential therapeutic agents |
WO2004016733A2 (en) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
WO2004070056A2 (en) | 2003-02-07 | 2004-08-19 | Diagnocure Inc. | Method to detect prostate cancer in a sample |
CA2563735C (en) | 2004-04-22 | 2020-07-14 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to steap-1 proteins |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
AU2006258655A1 (en) * | 2005-06-14 | 2006-12-21 | Dnavec Corporation | Method for production of antibody |
PT2845866T (en) | 2006-10-27 | 2017-08-09 | Genentech Inc | Antibodies and immunoconjugates and uses therefor |
EP3279315A3 (en) * | 2012-05-25 | 2018-02-28 | Cellectis | Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells |
CN104357451B (en) * | 2014-12-02 | 2016-09-21 | 广州市番禺区中心医院 | For the siRNA of DD3 gene and expression vector establishment thereof and application |
GB201513921D0 (en) * | 2015-08-05 | 2015-09-23 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers |
GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
GB201520566D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
IL297617B2 (en) * | 2016-12-22 | 2023-11-01 | Cue Biopharma Inc | T-cell modulatory multimeric polypeptides and methods of use thereof |
SG11201909218RA (en) | 2017-04-03 | 2019-11-28 | Hoffmann La Roche | Antibodies binding to steap-1 |
CN110988348B (en) * | 2019-11-06 | 2022-07-05 | 北京九强生物技术股份有限公司 | Free prostate specific antigen detection kit and preparation method thereof |
CN114250238B (en) * | 2021-11-26 | 2023-08-25 | 北京航空航天大学 | Gene-encoded neuron development regulatory polypeptide and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ331866A (en) * | 1996-03-15 | 2000-05-26 | Corixa Corp | Compounds for immunotherapy and immunodiagnosis of prostate cancer |
TR199902053T2 (en) * | 1997-02-25 | 2000-04-21 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use. |
CO4870792A1 (en) * | 1997-02-25 | 1999-12-27 | Corixa Corp | COMPOUNDS AND SET OF DIAGNOSTIC MEANS TO DETECT AND MONITOR THE PROGRESSION OF CANCER OF PROSTATE |
TW200532020A (en) * | 1998-07-14 | 2005-10-01 | Corixa Corp | Compositions and methods for therapy and diagnosis of prostate cancer |
AU7994200A (en) * | 1999-10-04 | 2001-05-10 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
WO2001034802A2 (en) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
-
2001
- 2001-01-16 CZ CZ20022756A patent/CZ20022756A3/en unknown
- 2001-01-16 WO PCT/US2001/001574 patent/WO2001051633A2/en not_active Application Discontinuation
- 2001-01-16 JP JP2001551207A patent/JP2003528591A/en active Pending
- 2001-01-16 CN CN01806526A patent/CN1436234A/en active Pending
- 2001-01-16 PL PL01356908A patent/PL356908A1/en unknown
- 2001-01-16 EP EP01906582A patent/EP1261708A2/en not_active Withdrawn
- 2001-01-16 BR BR0107643-4A patent/BR0107643A/en not_active Application Discontinuation
- 2001-01-16 KR KR1020027009144A patent/KR20030016217A/en not_active Application Discontinuation
- 2001-01-16 IL IL15073201A patent/IL150732A0/en unknown
- 2001-01-16 RU RU2002121771/13A patent/RU2002121771A/en unknown
- 2001-01-16 HU HU0203968A patent/HUP0203968A3/en unknown
- 2001-01-16 AU AU34474/01A patent/AU3447401A/en not_active Abandoned
- 2001-01-16 CA CA002397741A patent/CA2397741A1/en not_active Abandoned
- 2001-01-16 MX MXPA02006934A patent/MXPA02006934A/en unknown
-
2002
- 2002-07-15 NO NO20023402A patent/NO20023402L/en not_active Application Discontinuation
- 2002-08-12 ZA ZA200206400A patent/ZA200206400B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA02006934A (en) | 2003-01-28 |
WO2001051633A2 (en) | 2001-07-19 |
HUP0203968A2 (en) | 2003-03-28 |
WO2001051633A3 (en) | 2002-06-20 |
ZA200206400B (en) | 2004-01-21 |
CA2397741A1 (en) | 2001-07-19 |
WO2001051633A9 (en) | 2002-10-31 |
HUP0203968A3 (en) | 2004-09-28 |
EP1261708A2 (en) | 2002-12-04 |
NO20023402L (en) | 2002-08-29 |
BR0107643A (en) | 2003-06-10 |
AU3447401A (en) | 2001-07-24 |
NO20023402D0 (en) | 2002-07-15 |
RU2002121771A (en) | 2004-03-10 |
CN1436234A (en) | 2003-08-13 |
KR20030016217A (en) | 2003-02-26 |
IL150732A0 (en) | 2003-02-12 |
CZ20022756A3 (en) | 2003-02-12 |
JP2003528591A (en) | 2003-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203968A3 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
EP1515982A4 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2003302892A8 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
PL346359A1 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
PL366626A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
PL354093A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
PL365244A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
HUP0600780A2 (en) | Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
ZA200301204B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2002246519A8 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
IL158206A0 (en) | Compositions and methods for the prevention and treatment of human prostate cancer | |
EP1349485A4 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
EP1420814A4 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
PL366066A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU3483001A (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer |